Company Filing History:
Years Active: 2020-2024
Title: Christy Fryer: Innovator in Pharmaceutical Research
Introduction
Christy Fryer is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds and therapeutic methods. With a total of 2 patents, Fryer is recognized for his innovative approaches to addressing complex medical challenges.
Latest Patents
Fryer's latest patents include groundbreaking work on tricyclic AKR1C3 dependent KARS inhibitors. This invention relates to novel tricyclic compounds that serve as AKR1C3 dependent KARS inhibitors, along with processes for their preparation, pharmaceutical compositions, and their use in treating diseases and disorders mediated by this mechanism. Another significant patent involves antibodies against Notch 3, which targets specific conformational epitopes of the Notch 3 receptor, including its mutant forms. This patent outlines the compositions and methods for utilizing these antibodies in therapeutic applications.
Career Highlights
Fryer is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on innovative research that aims to improve patient outcomes through advanced therapeutic solutions. His contributions have been instrumental in the development of new treatments that address critical health issues.
Collaborations
Fryer collaborates with talented professionals in his field, including Chris Adair and Tracy Chen. These partnerships enhance the research and development process, fostering an environment of innovation and creativity.
Conclusion
Christy Fryer exemplifies the spirit of innovation in pharmaceutical research. His patents and work at Novartis AG highlight his commitment to advancing medical science and improving health outcomes.